论文部分内容阅读
儿童肺炎支原体肺炎(MPP)是由肺炎支原体(MP)引起的儿童急性下呼吸道感染性疾病,在儿童肺炎中发病率为10%~30%,流行期内发病率更高,以秋冬季为好发季节。目前MP已经成为儿童社区获得性肺炎的常见致病原,且出现了部分更小年龄的MPP。研究显示,除肺部损害,MP亦会导致肺外损伤,近年来肺外损害病例逐渐增加,部分病例甚至危及生命[1]。西医治疗MPP以大环内酯类抗生素为主,
Children with Mycoplasma pneumoniae Mycoplasma pneumonia (MPP) is caused by Mycoplasma pneumoniae (MP) acute lower respiratory tract infection in children with a prevalence of 10% to 30% in children with pneumonia, the prevalence was even higher in autumn and winter as well Season. Currently MP has become a common causative agent of children’s community-acquired pneumonia and some smaller ages of MPP have emerged. Studies have shown that, in addition to lung damage, MP can lead to extrapulmonary damage. In recent years, cases of extrapulmonary damage have gradually increased, and in some cases even life-threatening conditions have been reported [1]. Western medicine treatment MPP mainly macrolide antibiotics,